Guidelines Updated for Benign Paroxysmal Positional Vertigo

This article originally appeared here.
Share this content:
Guidelines Updated for Benign Paroxysmal Positional Vertigo
Guidelines Updated for Benign Paroxysmal Positional Vertigo

MONDAY, March 6, 2017 (HealthDay News) -- In a clinical practice guideline published in the March issue of Otolaryngology-Head and Neck Surgery, updated recommendations are presented for the diagnosis and management of benign paroxysmal positional vertigo (BPPV).

Neil Bhattacharyya, M.D., from Harvard Medical School in Boston, and colleagues reviewed the literature to update guidelines for BPPV. New evidence was included from two clinical practice guidelines, 20 systematic reviews, and 27 randomized controlled trials.

The authors made several strong recommendations, including that posterior semicircular canal BPPV should be diagnosed when vertigo associated with torsional, upbeating nystagmus is provoked by the Dix-Hallpike maneuver. Patients with posterior canal BPPV should be treated by or referred for treatment with a canalith repositioning procedure. For posterior canal BPPV, there was a strong recommendation against postprocedural postural restrictions. Recommendations also included use of the supine roll test to assess for lateral semicircular canal BPPV; differentiation of BPPV from other causes of imbalance, dizziness, and vertigo; assessing for factors that modify management; reassessment within one month to document resolution or persistence of symptoms; evaluation of persistent symptoms; and education of patients on the impact of BPPV in terms of safety, recurrence, and the importance of follow-up.

"In updating the guideline, it was our goal to do so utilizing a focused and transparent process, reconsidering more current evidence while ultimately factoring in BPPV treatments that result in improved quality of life for the patient," Bhattacharyya said in a statement.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Approves Admelog for Diabetes

FDA Approves Admelog for Diabetes

First drug approved as a follow-up product based on an abbreviated new process

High-Intensity Treadmill Exercise Feasible in Parkinson's Disease

High-Intensity Treadmill Exercise Feasible in Parkinson's Disease

Mean change in Unified Parkinson's Disease Rating Scale motor score lower for high-intensity exercise

is free, fast, and customized just for you!

Already a member?

Sign In Now »